Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.

Journal Article (Letter)

A new 30-gene signature has been described that separates prostate cancers of Gleason score ≤6 from those of Gleason score ≥8. It provides independent prognostic information for prostate cancers of intermediate risk (Gleason score of 7), which has the potential to stratify these patients into different risk groups. Clin Cancer Res; 23(1); 6-8. ©2016 AACRSee related article by Sinnott et al., p. 81.

Full Text

Duke Authors

Cited Authors

  • Yin, Y; Zhang, Q; Zhang, H; He, Y; Huang, J

Published Date

  • January 1, 2017

Published In

Volume / Issue

  • 23 / 1

Start / End Page

  • 6 - 8

PubMed ID

  • 27803045

Pubmed Central ID

  • PMC5215130

Electronic International Standard Serial Number (EISSN)

  • 1557-3265

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-16-2400


  • eng

Conference Location

  • United States